41 results on '"David B. Hanna"'
Search Results
2. Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection
- Author
-
Leila B. Giron, Qin Liu, Opeyemi S. Adeniji, Xiangfan Yin, Toshitha Kannan, Jianyi Ding, David Y. Lu, Susan Langan, Jinbing Zhang, Joao L. L. C. Azevedo, Shuk Hang Li, Sergei Shalygin, Parastoo Azadi, David B. Hanna, Igho Ofotokun, Jason Lazar, Margaret A. Fischl, Sabina Haberlen, Bernard Macatangay, Adaora A. Adimora, Beth D. Jamieson, Charles Rinaldo, Daniel Merenstein, Nadia R. Roan, Olaf Kutsch, Stephen Gange, Steven M. Wolinsky, Mallory D. Witt, Wendy S. Post, Andrew Kossenkov, Alan L. Landay, Ian Frank, Phyllis C. Tien, Robert Gross, Todd T. Brown, and Mohamed Abdel-Mohsen
- Subjects
Science - Abstract
Abstract People living with HIV (PLWH) experience increased vulnerability to premature aging and inflammation-associated comorbidities, even when HIV replication is suppressed by antiretroviral therapy (ART). However, the factors associated with this vulnerability remain uncertain. In the general population, alterations in the N-glycans on IgGs trigger inflammation and precede the onset of aging-associated diseases. Here, we investigate the IgG N-glycans in cross-sectional and longitudinal samples from 1214 women and men, living with and without HIV. PLWH exhibit an accelerated accumulation of pro-aging-associated glycan alterations and heightened expression of senescence-associated glycan-degrading enzymes compared to controls. These alterations correlate with elevated markers of inflammation and the severity of comorbidities, potentially preceding the development of such comorbidities. Mechanistically, HIV-specific antibodies glycoengineered with these alterations exhibit a reduced ability to elicit anti-HIV Fc-mediated immune activities. These findings hold potential for the development of biomarkers and tools to identify and prevent premature aging and comorbidities in PLWH.
- Published
- 2024
- Full Text
- View/download PDF
3. Metabolic and inflammatory perturbation of diabetes associated gut dysbiosis in people living with and without HIV infection
- Author
-
Kai Luo, Brandilyn A. Peters, Jee-Young Moon, Xiaonan Xue, Zheng Wang, Mykhaylo Usyk, David B. Hanna, Alan L. Landay, Michael F. Schneider, Deborah Gustafson, Kathleen M. Weber, Audrey French, Anjali Sharma, Kathryn Anastos, Tao Wang, Todd Brown, Clary B. Clish, Robert C. Kaplan, Rob Knight, Robert D. Burk, and Qibin Qi
- Subjects
HIV infection ,Diabetes ,Gut dysbiosis ,Gut metagenome ,Inflammatory proteome ,Blood metabolome ,Medicine ,Genetics ,QH426-470 - Abstract
Abstract Background Gut dysbiosis has been linked with both HIV infection and diabetes, but its interplay with metabolic and inflammatory responses in diabetes, particularly in the context of HIV infection, remains unclear. Methods We first conducted a cross-sectional association analysis to characterize the gut microbial, circulating metabolite, and immune/inflammatory protein features associated with diabetes in up to 493 women (~ 146 with prevalent diabetes with 69.9% HIV +) of the Women’s Interagency HIV Study. Prospective analyses were then conducted to determine associations of identified metabolites with incident diabetes over 12 years of follow-up in 694 participants (391 women from WIHS and 303 men from the Multicenter AIDS Cohort Study; 166 incident cases were recorded) with and without HIV infection. Mediation analyses were conducted to explore whether gut bacteria–diabetes associations are explained by altered metabolites and proteins. Results Seven gut bacterial genera were identified to be associated with diabetes (FDR-q
- Published
- 2024
- Full Text
- View/download PDF
4. Gut microbiota, circulating inflammatory markers and metabolites, and carotid artery atherosclerosis in HIV infection
- Author
-
Zheng Wang, Brandilyn A. Peters, MacKenzie Bryant, David B. Hanna, Tara Schwartz, Tao Wang, Christopher C. Sollecito, Mykhaylo Usyk, Evan Grassi, Fanua Wiek, Lauren St. Peter, Wendy S. Post, Alan L. Landay, Howard N. Hodis, Kathleen M. Weber, Audrey French, Elizabeth T. Golub, Jason Lazar, Deborah Gustafson, Anjali Sharma, Kathryn Anastos, Clary B. Clish, Robert D. Burk, Robert C. Kaplan, Rob Knight, and Qibin Qi
- Subjects
Gut microbiota ,Inflammatory markers ,Metabolomics ,Atherosclerosis ,HIV infection ,Microbial ecology ,QR100-130 - Abstract
Abstract Background Alterations in gut microbiota have been implicated in HIV infection and cardiovascular disease. However, how gut microbial alterations relate to host inflammation and metabolite profiles, and their relationships with atherosclerosis, have not been well-studied, especially in the context of HIV infection. Here, we examined associations of gut microbial species and functional components measured by shotgun metagenomics with carotid artery plaque assessed by B-mode carotid artery ultrasound in 320 women with or at high risk of HIV (65% HIV +) from the Women’s Interagency HIV Study. We further integrated plaque-associated microbial features with serum proteomics (74 inflammatory markers measured by the proximity extension assay) and plasma metabolomics (378 metabolites measured by liquid chromatography tandem mass spectrometry) in relation to carotid artery plaque in up to 433 women. Results Fusobacterium nucleatum, a potentially pathogenic bacteria, was positively associated with carotid artery plaque, while five microbial species (Roseburia hominis, Roseburia inulinivorans, Johnsonella ignava, Odoribacter splanchnicus, Clostridium saccharolyticum) were inversely associated with plaque. Results were consistent between women with and without HIV. Fusobacterium nucleatum was positively associated with several serum proteomic inflammatory markers (e.g., CXCL9), and the other plaque-related species were inversely associated with proteomic inflammatory markers (e.g., CX3CL1). These microbial-associated proteomic inflammatory markers were also positively associated with plaque. Associations between bacterial species (especially Fusobacterium nucleatum) and plaque were attenuated after further adjustment for proteomic inflammatory markers. Plaque-associated species were correlated with several plasma metabolites, including the microbial metabolite imidazole-propionate (ImP), which was positively associated with plaque and several pro-inflammatory markers. Further analysis identified additional bacterial species and bacterial hutH gene (encoding enzyme histidine ammonia-lyase in ImP production) associated with plasma ImP levels. A gut microbiota score based on these ImP-associated species was positively associated with plaque and several pro-inflammatory markers. Conclusion Among women living with or at risk of HIV, we identified several gut bacterial species and a microbial metabolite ImP associated with carotid artery atherosclerosis, which might be related to host immune activation and inflammation. Video Abstract
- Published
- 2023
- Full Text
- View/download PDF
5. Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells
- Author
-
Jenifer Vallejo, Ryosuke Saigusa, Rishab Gulati, Sujit Silas Armstrong Suthahar, Vasantika Suryawanshi, Ahmad Alimadadi, Christopher P. Durant, Yanal Ghosheh, Payel Roy, Erik Ehinger, Tanyaporn Pattarabanjird, David B. Hanna, Alan L. Landay, Russell P. Tracy, Jason M. Lazar, Wendy J. Mack, Kathleen M. Weber, Adaora A. Adimora, Howard N. Hodis, Phyllis C. Tien, Igho Ofotokun, Sonya L. Heath, Avishai Shemesh, Coleen A. McNamara, Lewis L. Lanier, Catherine C. Hedrick, Robert C. Kaplan, and Klaus Ley
- Subjects
CVD ,HIV ,scRNA-seq ,Transcriptomes ,Antibodies ,Human ,Biology (General) ,QH301-705.5 - Abstract
Abstract Background Cryopreserved peripheral blood mononuclear cells (PBMCs) are frequently collected and provide disease- and treatment-relevant data in clinical studies. Here, we developed combined protein (40 antibodies) and transcript single-cell (sc)RNA sequencing (scRNA-seq) in PBMCs. Results Among 31 participants in the Women’s Interagency HIV Study (WIHS), we sequenced 41,611 cells. Using Boolean gating followed by Seurat UMAPs (tool for visualizing high-dimensional data) and Louvain clustering, we identified 50 subsets among CD4+ T, CD8+ T, B, NK cells, and monocytes. This resolution was superior to flow cytometry, mass cytometry, or scRNA-seq without antibodies. Combined protein and transcript scRNA-seq allowed for the assessment of disease-related changes in transcriptomes and cell type proportions. As a proof-of-concept, we showed such differences between healthy and matched individuals living with HIV with and without cardiovascular disease. Conclusions In conclusion, combined protein and transcript scRNA sequencing is a suitable and powerful method for clinical investigations using PBMCs.
- Published
- 2022
- Full Text
- View/download PDF
6. Corrigendum to 'Risk Factor Control Across the Spectrum of Cardiovascular Risk: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)' [American Journal of Preventive Cardiology, Volume 5, March 2021, 100147]
- Author
-
Fatima Rodriguez, Un Jung Lee, Nicholas Barone, Katrina Swett, Lenny Lopez, Susan Cheng, Martha L. Daviglus, David B. Hanna, Rebeca A. Espinoza Giacinto, William Arguelles, Jianwen Cai, Gregory A. Talavera, and Carlos J. Rodriguez
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Public aspects of medicine ,RA1-1270 - Published
- 2022
- Full Text
- View/download PDF
7. Differential Impact of IL-32 Isoforms on the Functions of Coronary Artery Endothelial Cells: A Potential Link with Arterial Stiffness and Atherosclerosis
- Author
-
Rémi Bunet, Marie-Hélène Roy-Cardinal, Hardik Ramani, Aurélie Cleret-Buhot, Madeleine Durand, Carl Chartrand-Lefebvre, Jean-Pierre Routy, Réjean Thomas, Benoît Trottier, Petronela Ancuta, David B. Hanna, Alan L. Landay, Guy Cloutier, Cécile L. Tremblay, and Mohamed El-Far
- Subjects
HIV ,inflammation ,cardiovascular disease ,IL-32 ,arterial stiffness ,endothelial cell dysfunction ,Microbiology ,QR1-502 - Abstract
Chronic inflammation is associated with higher risk of cardiovascular disease (CVD) in people living with HIV (PLWH). We have previously shown that interleukin-32 (IL-32), a multi-isoform proinflammatory cytokine, is chronically upregulated in PLWH and is linked with CVD. However, the mechanistic roles of the different IL-32 isoforms in CVD are yet to be identified. In this study, we aimed to investigate the potential impact of IL-32 isoforms on coronary artery endothelial cells (CAEC), whose dysfunction represents a major factor for atherosclerosis. Our results demonstrated that the predominantly expressed IL-32 isoforms (IL-32β and IL-32γ) have a selective impact on the production of the proinflammatory cytokine IL-6 by CAEC. Furthermore, these two isoforms induced endothelial cell dysfunction by upregulating the expression of the adhesion molecules ICAM-I and VCAM-I and the chemoattractants CCL-2, CXCL-8 and CXCL-1. IL-32-mediated expression of these chemokines was sufficient to drive monocyte transmigration in vitro. Finally, we demonstrate that IL-32 expression in both PLWH and controls correlates with the carotid artery stiffness, measured by the cumulated lateral translation. These results suggest a role for IL-32-mediated endothelial cell dysfunction in dysregulation of the blood vessel wall and that IL-32 may represent a therapeutic target to prevent CVD in PLWH.
- Published
- 2023
- Full Text
- View/download PDF
8. Author Correction: Combined protein and transcript single-cell RNA sequencing in human peripheral blood mononuclear cells
- Author
-
Jenifer Vallejo, Ryosuke Saigusa, Rishab Gulati, Sujit Silas Armstrong Suthahar, Vasantika Suryawanshi, Ahmad Alimadadi, Christopher P. Durant, Yanal Ghosheh, Payel Roy, Erik Ehinger, Tanyaporn Pattarabanjird, David B. Hanna, Alan L. Landay, Russell P. Tracy, Jason M. Lazar, Wendy J. Mack, Kathleen M. Weber, Adaora A. Adimora, Howard N. Hodis, Phyllis C. Tien, Igho Ofotokun, Sonya L. Heath, Avishai Shemesh, Coleen A. McNamara, Lewis L. Lanier, Catherine C. Hedrick, Robert C. Kaplan, and Klaus Ley
- Subjects
Biology (General) ,QH301-705.5 - Published
- 2022
- Full Text
- View/download PDF
9. Upregulated IL-32 Expression And Reduced Gut Short Chain Fatty Acid Caproic Acid in People Living With HIV With Subclinical Atherosclerosis
- Author
-
Mohamed El-Far, Madeleine Durand, Isabelle Turcotte, Etienne Larouche-Anctil, Mohamed Sylla, Sarah Zaidan, Carl Chartrand-Lefebvre, Rémi Bunet, Hardik Ramani, Manel Sadouni, Irina Boldeanu, Annie Chamberland, Sylvie Lesage, Jean-Guy Baril, Benoit Trottier, Réjean Thomas, Emmanuel Gonzalez, Ali Filali-Mouhim, Jean-Philippe Goulet, Jeffrey A. Martinson, Seble Kassaye, Roksana Karim, Jorge R. Kizer, Audrey L. French, Stephen J. Gange, Petronela Ancuta, Jean-Pierre Routy, David B. Hanna, Robert C. Kaplan, Nicolas Chomont, Alan L. Landay, and Cécile L. Tremblay
- Subjects
HIV ,CVD (cardiovascular disease) ,inflammation ,atherosclerosis ,IL-32 ,gut microbiome ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Despite the success of antiretroviral therapy (ART), people living with HIV (PLWH) are still at higher risk for cardiovascular diseases (CVDs) that are mediated by chronic inflammation. Identification of novel inflammatory mediators with the inherent potential to be used as CVD biomarkers and also as therapeutic targets is critically needed for better risk stratification and disease management in PLWH. Here, we investigated the expression and potential role of the multi-isoform proinflammatory cytokine IL-32 in subclinical atherosclerosis in PLWH (n=49 with subclinical atherosclerosis and n=30 without) and HIV- controls (n=25 with subclinical atherosclerosis and n=24 without). While expression of all tested IL-32 isoforms (α, β, γ, D, ϵ, and θ) was significantly higher in peripheral blood from PLWH compared to HIV- controls, IL-32D and IL-32θ isoforms were further upregulated in HIV+ individuals with coronary artery atherosclerosis compared to their counterparts without. Upregulation of these two isoforms was associated with increased plasma levels of IL-18 and IL-1β and downregulation of the atheroprotective protein TRAIL, which together composed a unique atherosclerotic inflammatory signature specific for PLWH compared to HIV- controls. Logistic regression analysis demonstrated that modulation of these inflammatory variables was independent of age, smoking, and statin treatment. Furthermore, our in vitro functional data linked IL-32 to macrophage activation and production of IL-18 and downregulation of TRAIL, a mechanism previously shown to be associated with impaired cholesterol metabolism and atherosclerosis. Finally, increased expression of IL-32 isoforms in PLWH with subclinical atherosclerosis was associated with altered gut microbiome (increased pathogenic bacteria; Rothia and Eggerthella species) and lower abundance of the gut metabolite short-chain fatty acid (SCFA) caproic acid, measured in fecal samples from the study participants. Importantly, caproic acid diminished the production of IL-32, IL-18, and IL-1β in human PBMCs in response to bacterial LPS stimulation. In conclusion, our studies identified an HIV-specific atherosclerotic inflammatory signature including specific IL-32 isoforms, which is regulated by the SCFA caproic acid and that may lead to new potential therapies to prevent CVD in ART-treated PLWH.
- Published
- 2021
- Full Text
- View/download PDF
10. Risk factor control across the spectrum of cardiovascular risk: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
- Author
-
Fatima Rodriguez, Un Jung Lee, Nicholas Barone, Katrina Swett, Lenny Lopez, Susan Cheng, Martha L. Daviglus, David B. Hanna, Rebeca A. Espinoza Giacinto, William Arguelles, Jianwen Cai, Gregory A. Talavera, and Carlos J. Rodriguez
- Subjects
Cardiovascular prevention ,Hispanics ,Health disparities ,Hypercholesterolemia ,Diabetes ,Hypertension ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 ,Public aspects of medicine ,RA1-1270 - Abstract
Background: Presence of cardiovascular disease (CVD) risk factors (RFs) should prompt patients and their providers to work aggressively towards controlling those that are modifiable. The extent to which a greater CVD RF burden is related to CVD RF control in a contemporary and diverse Hispanic/Latino population is not well-understood. Methods: Using multicenter community-based data from the Hispanic Community Health Study/Study of Latinos, we assessed the self-reported prevalence of hypertension, hypercholesterolemia, diabetes, and prevalent CVD (ischemic heart disease or stroke). We used contemporaneous guidelines to define RF control. Multivariable logistic regression for complex survey sampling was used to examine whether having more CVD RFs was associated with CVD RF control (adjusting for age, sex, Hispanic background group, education, and health insurance). Results: Our sample included 8521 participants with at least one CVD RF or prevalent CVD. The mean age in HCHS/SOL target population was 49 (SE 0.3) years and 56% were women. Frequency of one, two, or three self-reported CVD RFs was 57%, 26%, 8%, respectively, and overall 9% of participants had prevalent CVD. After adjusting for sociodemographic factors, compared to those reporting one CVD RF, individuals with three CVD RFs were the least likely to have blood pressure, cholesterol, and glucose optimally controlled (odds ratio [OR]: 0.56; 95% confidence interval [CI]: 0.40–0.80). However, those with prevalent CVD were more likely to have all three risk factors controlled, (OR: 1.43; 95% CI: 1.01–2.01). Conclusion: Hispanic/Latino adults with three major CVD RFs represent a group with poor overall CVD RF control. Secondary CVD prevention fares better. The potential contributors to inadequate CVD RF control in this highly vulnerable group warrants further investigation.
- Published
- 2021
- Full Text
- View/download PDF
11. Relationship between area mortgage foreclosures, homeownership, and cardiovascular disease risk factors: The Hispanic Community Health Study/Study of Latinos
- Author
-
Earle C. Chambers, David B. Hanna, Simin Hua, Dustin T. Duncan, Marlene Camacho-Rivera, Shannon N. Zenk, Jessica L. McCurley, Krista Perreira, Marc D. Gellman, and Linda C. Gallo
- Subjects
Cardiovascular disease ,Housing ,Foreclosure ,Homeownership ,Public aspects of medicine ,RA1-1270 - Abstract
Abstract Background The risk of mortgage foreclosure disproportionately burdens Hispanic/Latino populations perpetuating racial disparities in health. In this study, we examined the relationship between area-level mortgage foreclosure risk, homeownership, and the prevalence of cardiovascular disease risk factors among participants of the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). Methods HCHS/SOL participants were age 18–74 years when recruited from four U.S. metropolitan areas. Mortgage foreclosure risk was obtained from the U.S. Department of Housing and Urban Development. Homeownership, sociodemographic factors, and cardiovascular disease risk factors were measured at baseline interview between 2008 and 2011. There were 13,856 individuals contributing to the analysis (median age 39 years old, 53% female). Results Renters in high foreclosure risk areas had a higher prevalence of hypertension and hypercholesterolemia but no association with smoking status compared to renters in low foreclosure risk areas. Renters were more likely to smoke cigarettes than homeowners. Conclusion Among US Hispanic/Latinos in urban cities, area foreclosure and homeownership have implications for risk of cardiovascular disease.
- Published
- 2019
- Full Text
- View/download PDF
12. HIV treatment outcomes among formerly incarcerated transitions clinic patients in a high prevalence setting
- Author
-
Mariya I. Masyukova, David B. Hanna, and Aaron D. Fox
- Subjects
HIV ,Incarceration ,Re-entry ,Primary care ,Retention in care ,Transitions clinic ,Public aspects of medicine ,RA1-1270 ,Social pathology. Social and public welfare. Criminology ,HV1-9960 - Abstract
Abstract Background Incarceration disproportionately affects people living with HIV/AIDS. When people are released from jail or prison, they face multiple barriers to HIV care, and those who do engage in care may have suboptimal HIV treatment outcomes. A limited number of studies have investigated HIV treatment outcomes among people who have been released from incarceration. Methods We conducted a retrospective cohort study comparing HIV viral load (VL) suppression and retention in care 12 months after entry into care among patients of a post-incarceration Transitions Clinic (TC) and a comparison group who received HIV care in the same community. Of 138 participants, 38 TC patients were matched to 100 non-TC controls based on age, race/ethnicity, gender, and date of HIV care entry. Results There was no significant difference in clinical study outcomes between TC and non-TC patients: 63% vs. 67% (p = 0.67) were retained in care and 54% vs. 63% (p = 0.33) had suppressed VL at 12 months. After adjusting for substance use disorder and viral load suppression at the start of treatment, the odds ratio of TC patients’ 12-month retention was 0.60 (95% CI 0.25–1.49) and VL suppression was 0.44 (95% CI 0.16–1.23) compared with non-TC patients. Conclusions Our findings show HIV care outcomes for patients at a post-incarceration Transitions Clinic that are similar to those of community-based comparison patients. The transitions clinic model, which provides medical, behavioral health, and supportive services to formerly incarcerated people, may be an effective model of care for this population; however, more scholarship is needed to quantify the components most effective in supporting retention in care and viral load suppression.
- Published
- 2018
- Full Text
- View/download PDF
13. Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
- Author
-
Claudio A. Bravo, Simin Hua, Amy Deik, Jason Lazar, David B. Hanna, Justin Scott, Jin Choul Chai, Robert C. Kaplan, Kathryn Anastos, Octavio A. Robles, Clary B. Clish, Jorge R. Kizer, and Qibin Qi
- Subjects
heart failure ,HIV ,left ventricular diastolic dysfunction ,metabolomics ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background People living with HIV have an increased risk of left ventricular diastolic dysfunction (LVDD) and heart failure. HIV‐associated LVDD may reflect both cardiomyocyte and systemic metabolic derangements, but the underlying pathways remain unclear. Methods and Results To explore such pathways, we conducted a pilot study in the Bronx and Brooklyn sites of the WIHS (Women's Interagency HIV Study) who participated in concurrent, but separate, metabolomics and echocardiographic ancillary studies. Liquid chromatography tandem mass spectrometry–based metabolomic profiling was performed on plasma samples from 125 HIV‐infected (43 with LVDD) and 35 HIV‐uninfected women (9 with LVDD). Partial least squares discriminant analysis identified polar metabolites and lipids in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways associated with LVDD. After multivariable adjustment, LVDD was significantly associated with higher concentrations of diacylglycerol 30:0 (odds ratio [OR], 1.60, 95% CI [1.01–2.55]); triacylglycerols 46:0 (OR 1.60 [1.04–2.48]), 48:0 (OR 1.63 [1.04–2.54]), 48:1 (OR 1.62 [1.01–2.60]), and 50:0 (OR 1.61 [1.02–2.53]); acylcarnitine C7 (OR 1.88 [1.21–2.92]), C9 (OR 1.99 [1.27–3.13]), and C16 (OR 1.80 [1.13–2.87]); as well as lower concentrations of phosphocholine (OR 0.59 [0.38–0.91]). There was no evidence of effect modification of these relationships by HIV status. Conclusions In this pilot study, women with or at risk of HIV with LVDD showed alterations in plasma metabolites in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways. Although these findings require replication, they suggest that improved understanding of metabolic perturbations and their potential modification could offer new approaches to prevent cardiac dysfunction in this high‐risk group.
- Published
- 2020
- Full Text
- View/download PDF
14. Adjudicated Heart Failure in HIV‐Infected and Uninfected Men and Women
- Author
-
Matthew J. Feinstein, Alexandra B. Steverson, Hongyan Ning, Anna E. Pawlowski, Daniel Schneider, Faraz S. Ahmad, Jes M. Sanders, Arjun Sinha, Robin M. Nance, Chad J. Achenbach, J. A. Christopher Delaney, Susan R. Heckbert, Sanjiv J. Shah, David B. Hanna, Priscilla Y. Hsue, Gerald S. Bloomfield, Chris T. Longenecker, Heidi M. Crane, and Donald M. Lloyd‐Jones
- Subjects
heart failure ,HIV ,immunology ,inflammation ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background HIV is associated with elevated risk of heart failure (HF). Despite poor agreement between automated, administrative code–based HF definitions and physician‐adjudicated HF, no studies have evaluated incident adjudicated HF for people living with HIV (PLWH). Methods and Results We analyzed PLWH and uninfected controls receiving care in an urban medical system from January 1, 2000, to July 12, 2016. Physicians reviewed data from medical records to adjudicate HF diagnoses. We used multivariable‐adjusted Cox models to analyze incident HF for PLWH versus controls and HIV‐related factors associated with incident HF. We also analyzed the performance of automated versus physician‐adjudicated HF definitions. Incident adjudicated HF occurred in 97 of 4640 PLWH (2.1%; mean: 6.8 years to HF) and 55 of 4250 controls (1.3%; mean: 6.7 years to HF; multivariable‐adjusted hazard ratio: 2.10; 95% confidence interval, 1.38–3.21). Among PLWH, higher HIV viral load (hazard ratio per log10 higher time‐updated viral load: 1.22; 95% confidence interval, 1.11–1.33) was associated with greater HF risk and higher CD4+ T cell count was associated with lower HF risk (hazard ratio per 100 cells/mm3 higher time‐updated CD4 count: 0.80; 95% confidence interval, 0.69–0.92). In exploratory analyses, the most accurate automated HF definitions had sensitivities of 67% to 75% and positive predictive values of 54% to 60%. Conclusions In a cohort with rigorous HF adjudication, PLWH had greater risks of HF than uninfected people after adjustment for demographics and cardiovascular risk factors. Higher HIV viral load and lower CD4+ T cell count were associated with higher HF risk among PLWH. Automated methods of HF ascertainment exhibited poor accuracy for PLWH and uninfected people.
- Published
- 2018
- Full Text
- View/download PDF
15. ASSOCIATION OF SOCIAL NEEDS WITH UNCONTROLLED VIREMIA IN PEOPLE WITH HIV
- Author
-
David B. Hanna, Uriel R. Felsen, Kathryn Anastos, Laurie J. Bauman, Kevin P. Fiori, Mindy S. Ginsberg, Dana Watnick, and Earle C. Chambers
- Subjects
Infectious Diseases ,Social Psychology ,Public Health, Environmental and Occupational Health ,Article - Abstract
Using a tool integrated into the electronic health record, we determined prevalence of 10 social needs among 377 people with HIV (PWH) and 27,833 patients without HIV receiving care in the Montefiore Health System. PWH (median age 53) were 55% women, 41% Black, 44% Hispanic. 33% of PWH reported at least one social need vs. 18% among patients without HIV, with healthcare transportation and housing needs significantly higher in PWH in adjusted analyses. PWH reporting transportation needs were 27% less likely to be virologically suppressed (
- Published
- 2022
16. Higher Neighborhood Population Density Is Associated with Lower Potassium Intake in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
- Author
-
Marc D. Gellman, Judith Wylie-Rosett, Andrew Rundle, Kiarri N. Kershaw, Robert C. Kaplan, Gina S. Lovasi, Franklyn Gonzalez, Linda Van Horn, Pamela A. Shaw, Yasmin Mossavar-Rahmani, Simin Hua, and David B. Hanna
- Subjects
Male ,Potassium intake ,Health, Toxicology and Mutagenesis ,Potassium ,chemistry.chemical_element ,Population density ,Article ,Residence Characteristics ,Risk Factors ,Environmental health ,Humans ,Medicine ,Latinos ,food environment ,population density ,neighborhood ,business.industry ,potassium ,Confounding ,Public Health, Environmental and Occupational Health ,Hispanic or Latino ,regression calibration ,Hchs sol ,built environment ,United States ,nutrition ,Quartile ,chemistry ,Community health ,Household income ,Female ,Self Report ,Hispanic Americans ,business - Abstract
Current U.S. dietary guidelines recommend a daily potassium intake of 3400 mg/day for men and 2600 mg/day for women. Sub-optimal access to nutrient-rich foods may limit potassium intake and increase cardiometabolic risk. We examined the association of neighborhood characteristics related to food availability with potassium intake in the Hispanic Community Health Study/Study of Latinos (HCHS/SOL). 13,835 participants completed a 24-h dietary recall assessment and had complete covariates. Self-reported potassium intake was calibrated with an objective 24-h urinary potassium biomarker, using equations developed in the SOL Nutrition &, Physical Activity Assessment Study (SOLNAS, N = 440). Neighborhood population density, median household income, Hispanic/Latino diversity, and a retail food environment index by census tract were obtained. Linear regression assessed associations with 24-h potassium intake, adjusting for individual-level and neighborhood confounders. Mean 24-h potassium was 2629 mg/day based on the SOLNAS biomarker and 2702 mg/day using multiple imputation and HCHS/SOL biomarker calibration. Compared with the lowest quartile of neighborhood population density, living in the highest quartile was associated with a 26% lower potassium intake in SOLNAS (adjusted fold-change 0.74, 95% CI 0.59–0.94) and a 39% lower intake in HCHS/SOL (adjusted fold-change 0.61 95% CI 0.45–0.84). Results were only partially explained by the retail food environment. The mechanisms by which population density affects potassium intake should be further studied.
- Published
- 2021
17. Risk factor control across the spectrum of cardiovascular risk: Findings from the Hispanic Community Health Study/Study of Latinos (HCHS/SOL)
- Author
-
Carlos J. Rodriguez, Katrina Swett, William Arguelles, Martha L. Daviglus, David B. Hanna, Fatima Rodriguez, Rebeca A. Espinoza Giacinto, Nicholas Barone, Lenny Lopez, Un Jung Lee, Gregory A. Talavera, Susan Cheng, and Jianwen Cai
- Subjects
lcsh:Diseases of the circulatory (Cardiovascular) system ,Hispanics ,Hypercholesterolemia ,Logistic regression ,Diabetes mellitus ,medicine ,cardiovascular diseases ,Risk factor ,Stroke ,Original Research ,business.industry ,lcsh:Public aspects of medicine ,Diabetes ,lcsh:RA1-1270 ,General Medicine ,Odds ratio ,medicine.disease ,Confidence interval ,Health equity ,Cardiovascular prevention ,lcsh:RC666-701 ,Community health ,Hypertension ,Health disparities ,Corrigendum ,business ,Demography - Abstract
Background Presence of cardiovascular disease (CVD) risk factors (RFs) should prompt patients and their providers to work aggressively towards controlling those that are modifiable. The extent to which a greater CVD RF burden is related to CVD RF control in a contemporary and diverse Hispanic/Latino population is not well-understood. Methods Using multicenter community-based data from the Hispanic Community Health Study/Study of Latinos, we assessed the self-reported prevalence of hypertension, hypercholesterolemia, diabetes, and prevalent CVD (ischemic heart disease or stroke). We used contemporaneous guidelines to define RF control. Multivariable logistic regression for complex survey sampling was used to examine whether having more CVD RFs was associated with CVD RF control (adjusting for age, sex, Hispanic background group, education, and health insurance). Results Our sample included 8521 participants with at least one CVD RF or prevalent CVD. The mean age in HCHS/SOL target population was 49 (SE 0.3) years and 56% were women. Frequency of one, two, or three self-reported CVD RFs was 57%, 26%, 8%, respectively, and overall 9% of participants had prevalent CVD. After adjusting for sociodemographic factors, compared to those reporting one CVD RF, individuals with three CVD RFs were the least likely to have blood pressure, cholesterol, and glucose optimally controlled (odds ratio [OR]: 0.56; 95% confidence interval [CI]: 0.40–0.80). However, those with prevalent CVD were more likely to have all three risk factors controlled, (OR: 1.43; 95% CI: 1.01–2.01). Conclusion Hispanic/Latino adults with three major CVD RFs represent a group with poor overall CVD RF control. Secondary CVD prevention fares better. The potential contributors to inadequate CVD RF control in this highly vulnerable group warrants further investigation.
- Published
- 2021
18. Classical monocyte transcriptomes reveal significant anti-inflammatory statin effect in women with chronic HIV
- Author
-
Phyllis C. Tien, Christopher P. Durant, Igho Ofotokun, Konrad Buscher, Russell P. Tracy, Howard N. Hodis, Tao Wang, Wendy J. Mack, Yanal Ghosheh, Livia Baas, Kathryn Anastos, Mardge H. Cohen, Akula Bala Pramod, Sonya L. Heath, Karin A Mueller, Jason Lazar, Qibin Qi, Erik Ehinger, Robert C. Kaplan, Stephen J. Gange, Alan L. Landay, David B. Hanna, Juan Lin, and Klaus Ley
- Subjects
0301 basic medicine ,Oncology ,medicine.medical_specialty ,Statin ,Physiology ,medicine.drug_class ,Population ,HIV Infections ,Disease ,030204 cardiovascular system & hematology ,Lower risk ,Peripheral blood mononuclear cell ,Monocytes ,03 medical and health sciences ,0302 clinical medicine ,Physiology (medical) ,Internal medicine ,Antiretroviral Therapy, Highly Active ,medicine ,Humans ,Myocardial infarction ,education ,Subclinical infection ,education.field_of_study ,business.industry ,Original Articles ,medicine.disease ,Atherosclerosis ,Comorbidity ,030104 developmental biology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Aims During virally suppressed chronic HIV infection, persistent inflammation contributes to the development of cardiovascular disease (CVD), a major comorbidity in people living with HIV (LWH). Classical blood monocytes (CMs) remain activated during antiretroviral therapy and are a major source of pro-inflammatory and pro-thrombotic factors that contribute to atherosclerotic plaque development and instability. Methods and results Here, we identify transcriptomic changes in circulating CMs in peripheral blood mononuclear cell samples from participants of the Women’s Interagency HIV Study, selected by HIV and subclinical CVD (sCVD) status. We flow-sorted CM from participants of the Women’s Interagency HIV Study and deep-sequenced their mRNA (n = 92). CMs of HIV+ participants showed elevated interleukin (IL)-6, IL-1β, and IL-12β, overlapping with many transcripts identified in sCVD+ participants. In sCVD+ participants LWH, those reporting statin use showed reduced pro-inflammatory gene expression to a level comparable with healthy (HIV−sCVD−) participants. Statin non-users maintained an elevated inflammatory profile and increased cytokine production. Conclusion Statin therapy has been associated with a lower risk of cardiac events, such as myocardial infarction in the general population, but not in those LWH. Our data suggest that women LWH may benefit from statin therapy even in the absence of overt CVD.
- Published
- 2020
19. Metabolomic Profiling of Left Ventricular Diastolic Dysfunction in Women With or at Risk for HIV Infection: The Women's Interagency HIV Study
- Author
-
Jin Choul Chai, Octavio A. Robles, Kathryn Anastos, Justin M. Scott, Simin Hua, David B. Hanna, Clary B. Clish, Claudio Bravo, Qibin Qi, Amy Deik, Robert C. Kaplan, Jason Lazar, and Jorge R. Kizer
- Subjects
Adult ,medicine.medical_specialty ,left ventricular diastolic dysfunction ,Human immunodeficiency virus (HIV) ,heart failure ,HIV Infections ,Pilot Projects ,030204 cardiovascular system & hematology ,medicine.disease_cause ,Risk Assessment ,Ventricular Function, Left ,03 medical and health sciences ,Ventricular Dysfunction, Left ,0302 clinical medicine ,Sex Factors ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,Original Research ,Go Red for Women Spotlight ,business.industry ,HIV ,Odds ratio ,Women's Interagency HIV Study ,Middle Aged ,medicine.disease ,Prognosis ,metabolomics ,United States ,3. Good health ,Increased risk ,Metabolomic profiling ,Metabolism ,Heart Disease Risk Factors ,Heart failure ,Case-Control Studies ,Cardiology ,Left ventricular diastolic dysfunction ,Female ,Hiv status ,Cardiology and Cardiovascular Medicine ,business ,Energy Metabolism ,Biomarkers - Abstract
Background People living with HIV have an increased risk of left ventricular diastolic dysfunction ( LVDD ) and heart failure. HIV ‐associated LVDD may reflect both cardiomyocyte and systemic metabolic derangements, but the underlying pathways remain unclear. Methods and Results To explore such pathways, we conducted a pilot study in the Bronx and Brooklyn sites of the WIHS (Women's Interagency HIV Study) who participated in concurrent, but separate, metabolomics and echocardiographic ancillary studies. Liquid chromatography tandem mass spectrometry–based metabolomic profiling was performed on plasma samples from 125 HIV‐infected (43 with LVDD) and 35 HIV‐uninfected women (9 with LVDD). Partial least squares discriminant analysis identified polar metabolites and lipids in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways associated with LVDD . After multivariable adjustment, LVDD was significantly associated with higher concentrations of diacylglycerol 30:0 (odds ratio [ OR ], 1.60, 95% CI [1.01–2.55]); triacylglycerols 46:0 ( OR 1.60 [1.04–2.48]), 48:0 ( OR 1.63 [1.04–2.54]), 48:1 ( OR 1.62 [1.01–2.60]), and 50:0 ( OR 1.61 [1.02–2.53]); acylcarnitine C7 ( OR 1.88 [1.21–2.92]), C9 ( OR 1.99 [1.27–3.13]), and C16 ( OR 1.80 [1.13–2.87]); as well as lower concentrations of phosphocholine ( OR 0.59 [0.38–0.91]). There was no evidence of effect modification of these relationships by HIV status. Conclusions In this pilot study, women with or at risk of HIV with LVDD showed alterations in plasma metabolites in the glycerophospholipid‐metabolism and fatty‐acid‐oxidation pathways. Although these findings require replication, they suggest that improved understanding of metabolic perturbations and their potential modification could offer new approaches to prevent cardiac dysfunction in this high‐risk group.
- Published
- 2020
20. ELEVATED MICROPARTICLE TISSUE FACTOR ACTIVITY IS ASSOCIATED WITH CAROTID ARTERY PLAQUE IN HIV INFECTED WOMEN
- Author
-
Kathryn Anastos, Mardge H. Cohen, Robert C. Kaplan, Xiaonan Xue, Jason Lazar, Russell P. Tracy, Wendy J. Mack, Chenglong Liu, Alan L. Landay, Phyllis C. Tien, Cathy Tilley, Stephen J. Gange, David B. Hanna, Juan Lin, and Howard N. Hodis
- Subjects
Adult ,medicine.medical_specialty ,Inflammation ,HIV Infections ,Gastroenterology ,Article ,Thromboplastin ,Tissue factor ,Internal medicine ,medicine ,Humans ,Pharmacology (medical) ,Carotid Stenosis ,Interleukin 6 ,Ultrasonography ,biology ,business.industry ,Monocyte ,C-reactive protein ,Case-control study ,Odds ratio ,Middle Aged ,medicine.disease ,Thrombosis ,Infectious Diseases ,medicine.anatomical_structure ,Case-Control Studies ,biology.protein ,Female ,medicine.symptom ,business - Abstract
Background Expression of tissue factor (TF) on the surface of activated monocytes may trigger thrombosis, leading to clotting risk, inflammation, and atherosclerosis. TF-positive microparticles (MP-TF) represent a functionally active form of TF that may be promulgated by long-term HIV infection. We hypothesized that greater MP-TF activity is associated with carotid artery plaque in HIV+ women. Setting In a case-control study nested within the Women's Interagency HIV Study (WIHS), eligible HIV+ participants underwent B-mode carotid artery ultrasound at 2 study visits occurring 7 years apart. Cases were defined by the presence of at least 1 carotid artery plaque assessed at either visit. Cases were matched 1:2 to controls who were found not to have carotid artery plaques. Methods Conditional logistic regression estimated the association of MP-TF activity with the presence of carotid artery plaque, adjusting for demographic and behavioral characteristics, HIV-related factors, cardiometabolic risk factors, and serum inflammation biomarkers (high-sensitivity C-reactive protein, IL-6, sCD14, sCD163, Gal-3, and Gal-3BP). Results Elevated MP-TF activity (>0.537 pg/mL) was found to be significantly associated with greater odds of plaque (adjusted odds ratio 3.86, 95% confidence interval: 1.06 to 14.07, P = 0.04). The association was attenuated after further adjustment for IL-6 but was unaffected by adjustment for other biomarkers including those denoting monocyte activation. Conclusions Our findings suggest a link among HIV infection, innate immune system perturbation, coagulation, and atherosclerosis.
- Published
- 2019
21. Cumulative Human Immunodeficiency Viremia, Antiretroviral Therapy, and Incident Myocardial Infarction
- Author
-
Jessica Williams-Nguyen, Heidi M. Crane, Joseph A.C. Delaney, Mathew J. Feinstein, William C. Mathews, Michael J. Mugavero, Susan R. Heckbert, Richard D. Moore, Joseph J. Eron, Bridget M. Whitney, Michael S. Saag, Matthew J. Budoff, Robert C. Kaplan, Elvin Geng, Robin M. Nance, Greer A. Burkholder, David B. Hanna, Peter W. Hunt, Daniel R. Drozd, and Mari M. Kitahata
- Subjects
Male ,Epidemiology ,Human immunodeficiency virus (HIV) ,Myocardial Infarction ,Marginal structural model ,HIV Infections ,medicine.disease_cause ,Cardiovascular ,01 natural sciences ,Cohort Studies ,010104 statistics & probability ,0302 clinical medicine ,Antiretroviral Therapy, Highly Active ,030212 general & internal medicine ,Myocardial infarction ,Statistics ,virus diseases ,Viral Load ,Middle Aged ,Heart Disease ,Infectious Diseases ,Public Health and Health Services ,HIV/AIDS ,Female ,Viral load ,inverse probability weighting ,Cohort study ,Adult ,medicine.medical_specialty ,Clinical Trials and Supportive Activities ,Antiretroviral Therapy ,Viremia ,Article ,03 medical and health sciences ,Clinical Research ,Internal medicine ,medicine ,Humans ,Highly Active ,Marginal structural models ,0101 mathematics ,Heart Disease - Coronary Heart Disease ,Proportional Hazards Models ,business.industry ,Proportional hazards model ,Prevention ,HIV ,medicine.disease ,Antiretroviral therapy ,United States ,business - Abstract
Background: People living with HIV are at risk of increased myocardial infarction (MI). Cumulative HIV viral load (VL) has been proposed as a better measure of HIV inflammation than other measures of VL, like baseline VL, but its associations with MI are not known. Methods: The multisite Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort includes clinical data and centrally adjudicated MI with distinction between atheroembolic MI (type 1) and MI related to supply-demand mismatch (type 2). We examined CNICS participants who were not on antiretroviral therapy (ART) at enrollment. Cumulative VL (copy-days of virus) from 6 months after enrollment was estimated with a time-weighted sum using the trapezoidal rule. We modeled associations of cumulative and baseline VL with MI by type using marginal structural Cox models. We contrasted the 75% percentile of the VL distribution with the 25% percentile. Results: Among 11,324 participants, 218 MIs occurred between 1996 and 2016. Higher cumulative VL was associated with risk of all MI (hazard ratio [HR] = 1.72; 95% confidence interval [CI] = 1.26, 2.36), type 1 MI (HR = 1.23; 95% CI = 0.78, 1.96), and type 2 MI (HR = 2.52; 95% CI = 1.74, 3.66). While off ART, cumulative VL had a stronger association with type 1 MI (HR = 2.13; 95% CI = 1.15, 3.94) than type 2 MI (HR = 1.25; 95% CI = 0.70, 2.25). Baseline VL was associated with all MI (HR = 1.60; 95% CI = 1.28, 2.01), type 1 MI (HR = 1.73; 95% CI = 1.26, 2.38), and type 2 MI (HR = 1.51; 95% CI = 1.10, 2.08). Conclusions: Higher cumulative and baseline VL is associated with all MI, with a particularly strong association between cumulative VL and type 2 MI.
- Published
- 2019
- Full Text
- View/download PDF
22. Plasma Tryptophan-Kynurenine Metabolites Are Altered in Human Immunodeficiency Virus Infection and Associated With Progression of Carotid Artery Atherosclerosis
- Author
-
Robert C. Kaplan, Tao Wang, Justin Scott, Qibin Qi, Howard N. Hodis, Marshall J. Glesby, Alan L. Landay, Simin Hua, Clary B. Clish, Sanjiv J. Shah, Robert D. Burk, Kathryn Anastos, Sabina A. Haberlen, David B. Hanna, Wendy S. Post, and Jason Lazar
- Subjects
0301 basic medicine ,Microbiology (medical) ,Adult ,Carotid Artery Diseases ,Male ,medicine.medical_specialty ,Metabolite ,Multicenter AIDS Cohort Study ,HIV Infections ,CD38 ,03 medical and health sciences ,chemistry.chemical_compound ,Kynurenic acid ,Internal medicine ,Medicine ,Humans ,Prospective Studies ,Prospective cohort study ,Articles and Commentaries ,Kynurenine ,business.industry ,Tryptophan ,Middle Aged ,030104 developmental biology ,Infectious Diseases ,Blood pressure ,Endocrinology ,Carotid Arteries ,chemistry ,Disease Progression ,Female ,business ,Biomarkers - Abstract
BACKGROUND: It is unknown whether disrupted tryptophan catabolism is associated with cardiovascular disease (CVD) in human immunodeficiency virus (HIV)–infected individuals. METHODS: Plasma tryptophan and kynurenic acid were measured in 737 women and men (520 HIV+, 217 HIV−) from the Women’s Interagency HIV Study and the Multicenter AIDS Cohort Study. Repeated B-mode carotid artery ultrasound imaging was obtained from 2004 through 2013. We examined associations of baseline tryptophan, kynurenic acid, and kynurenic acid-to-tryptophan (KYNA/TRP) ratio, with risk of carotid plaque. RESULTS: After a 7-year follow-up, 112 participants developed carotid plaque. Compared to those without HIV infection, HIV-infected participants had lower tryptophan (P < .001), higher KYNA/TRP (P = .01), and similar kynurenic acid levels (P = .51). Tryptophan, kynurenic acid, and KYNA/TRP were correlated with T-cell activation (CD38+HLA-DR+) and immune activation markers (serum sCD14, galectin-3) but had few correlations with interleukin-6, C-reactive protein, or CVD risk factors (blood pressure, lipids). Adjusted for demographic and behavioral factors, each standard deviation (SD) increment in tryptophan was associated with a 29% (95% confidence interval [CI], 17%–38%) decreased risk of carotid plaque (P < .001), while each SD increment in kynurenic acid (P = .02) and KYNA/TRP (P < .001) was associated with a 34% (6%–69%) and a 47% (26%–73%) increased risk of carotid plaque, respectively. After further adjustment for CVD risk factors and immune activation markers, these associations were attenuated but remained significant. CONCLUSIONS: Plasma tryptophan-kynurenine metabolites are altered in HIV infection and associated with progression of carotid artery atherosclerosis.
- Published
- 2018
23. HIV outcomes among migrants from low- and middle-income countries living in high-income countries: a review of recent evidence
- Author
-
Jonathan Ross, David B. Hanna, and Chinazo O. Cunningham
- Subjects
Microbiology (medical) ,media_common.quotation_subject ,Immigration ,Human immunodeficiency virus (HIV) ,HIV Infections ,medicine.disease_cause ,Article ,Health Services Accessibility ,03 medical and health sciences ,0302 clinical medicine ,Environmental health ,medicine ,Disease Transmission, Infectious ,Humans ,030212 general & internal medicine ,media_common ,Transients and Migrants ,030505 public health ,business.industry ,Transmission (medicine) ,Social distance ,Developed Countries ,Hiv epidemiology ,virus diseases ,Disease Management ,Low income and middle income countries ,Infectious Diseases ,Treatment Outcome ,Psychological Distance ,Socioeconomic Factors ,0305 other medical science ,business ,High income countries ,Developed country - Abstract
Migrants living in high-income countries are disproportionately affected by HIV infection and frequently have characteristics associated with poor HIV clinical outcomes. HIV epidemiology among migrants is influenced by changes in migration patterns and variations in transmission risk behaviors. Here we review the recently published literature on known HIV outcomes among migrants from low-income and middle-income countries living in high-income countries.High proportions of migrants acquire HIV after migration, and this group frequently presents to care late. Once established in care, migrants are often more likely to experience worse HIV treatment outcomes compared with native populations. Multiple individual and structural factors influence HIV diagnosis and treatment outcomes among migrants, including disruption of social networks, increased sexual risk behaviors, communication barriers, limited access to care, and stigma. Few studies have examined interventions targeted at improving HIV outcomes among migrants.Stigma and limited access to care appear to be primary drivers of poor HIV outcomes among migrants in high-income countries. Addressing these disparities is limited by difficulties in identifying and monitoring this population as well as a lack of evidence regarding appropriate interventions for migrants living with HIV. Improving outcomes for this group requires interventions that are specifically targeted at this marginalized and growing population.
- Published
- 2018
24. Low Birth Weight in Human Immunodeficiency Virus–Exposed Uninfected Infants in Bronx, New York
- Author
-
Betsy C Herold, Jasmeen Dara, David B. Hanna, Rodney L. Wright, and Kathryn Anastos
- Subjects
0301 basic medicine ,Male ,medicine.medical_specialty ,Birth weight ,Gestational Age ,HIV Infections ,Birth certificate ,Electronic Articles ,03 medical and health sciences ,0302 clinical medicine ,Pregnancy ,Risk Factors ,medicine ,Humans ,030212 general & internal medicine ,Pregnancy Complications, Infectious ,Prospective cohort study ,Retrospective Studies ,Obstetrics ,business.industry ,Infant, Newborn ,Gestational age ,virus diseases ,Retrospective cohort study ,General Medicine ,HIV Protease Inhibitors ,Infant, Low Birth Weight ,medicine.disease ,Infectious Disease Transmission, Vertical ,Low birth weight ,030104 developmental biology ,Infectious Diseases ,Prenatal Exposure Delayed Effects ,Pediatrics, Perinatology and Child Health ,Gestation ,Female ,New York City ,medicine.symptom ,business ,Infant, Premature - Abstract
BACKGROUND: Prevention of mother-to-child transmission of human immunodeficiency virus (HIV) with antiretroviral therapy (ART) has been highly successful. However, HIV-exposed uninfected (HIV-EU) infants might be at increased risk for low birth weight and/or preterm birth. We compared the birth weights and gestational ages of HIV-EU infants to those of HIV-unexposed control infants in Bronx, New York, an epicenter of the HIV epidemic in the United States. METHODS: This study was performed with a retrospective cohort of HIV-EU infants born at Montefiore Medical Center between 2008 and 2012 and HIV-unexposed control infants. Each HIV-EU infant was matched according to year of birth with 5 HIV-unexposed controls from the New York City Department of Health and Mental Hygiene birth certificate database. We used regression models to assess the association between HIV exposure and birth weight while controlling for potential confounders. A secondary analysis was performed to determine the association of maternal protease inhibitor–based ART use and birth weight among HIV-EU infants. RESULTS: We included 155 HIV-EU infants born between 2008 and 2012 (51% female, 61% black, 32% Hispanic) and 775 HIV-unexposed infants. The mean (± standard deviation) unadjusted birth weights were 2971 ± 616 g (HIV-EU infants) and 3163 ± 644 g (HIV-unexposed infants) (P < .01). Multivariable regression revealed significantly lower birth weight for the HIV-EU infants (difference, −101.5 g [95% confidence interval, −181.4 to −21.6]). We found no difference in mean birth weight or gestational age with maternal protease inhibitor–based ART use when compared to the use of other regimens. CONCLUSIONS: We found significantly lower birth weight among HIV-EU infants. Long-term prospective studies are necessary to determine the implications of this finding on infant growth and development.
- Published
- 2017
25. Genome-wide admixture and association study of subclinical atherosclerosis in the Women’s Interagency HIV Study (WIHS)
- Author
-
Jason Lazar, Degui Zhi, Michelle Floris-Moore, Qibin Qi, Howard W. Wiener, David B. Hanna, Aditi Shendre, Edgar T. Overton, Marguerite R. Irvin, Bradley E. Aouizerat, Kathleen M. Weber, Chenglong Liu, Stephen J. Gange, Howard N. Hodis, Robert C. Kaplan, Sadeep Shrestha, Nita A. Limdi, and Ighovwerha Ofotokun
- Subjects
0301 basic medicine ,Oxidoreductase complex ,RNA viruses ,lcsh:Medicine ,Genome-wide association study ,HIV Infections ,Cardiovascular Medicine ,Pathology and Laboratory Medicine ,Vascular Medicine ,Geographical Locations ,Cohort Studies ,Intergenic region ,Mathematical and Statistical Techniques ,Immunodeficiency Viruses ,Medicine and Health Sciences ,lcsh:Science ,Genetics ,Multidisciplinary ,Women's Interagency HIV Study ,Genomics ,3. Good health ,Europe ,Medical Microbiology ,Cardiovascular Diseases ,Viral Pathogens ,Viruses ,Physical Sciences ,Female ,Pathogens ,Statistics (Mathematics) ,Research Article ,Pseudogene ,Single-nucleotide polymorphism ,Biology ,Research and Analysis Methods ,Genome Complexity ,Microbiology ,Molecular Genetics ,03 medical and health sciences ,Chromosome 19 ,Retroviruses ,Genome-Wide Association Studies ,SNP ,Humans ,Statistical Methods ,Microbial Pathogens ,Molecular Biology ,lcsh:R ,Lentivirus ,Organisms ,Biology and Life Sciences ,Computational Biology ,HIV ,Human Genetics ,Genome Analysis ,Atherosclerosis ,Introns ,Black or African American ,030104 developmental biology ,Case-Control Studies ,People and Places ,lcsh:Q ,Mathematics ,Meta-Analysis ,Genome-Wide Association Study - Abstract
Cardiovascular disease (CVD) is a major comorbidity among HIV-infected individuals. Common carotid artery intima-media thickness (cCIMT) is a valid and reliable subclinical measure of atherosclerosis and is known to predict CVD. We performed genome-wide association (GWA) and admixture analysis among 682 HIV-positive and 288 HIV-negative Black, non-Hispanic women from the Women’s Interagency HIV study (WIHS) cohort using a combined and stratified analysis approach. We found some suggestive associations but none of the SNPs reached genome-wide statistical significance in our GWAS analysis. The top GWAS SNPs were rs2280828 in the region intergenic to mediator complex subunit 30 and exostosin glycosyltransferase 1 (MED30 | EXT1) among all women, rs2907092 in the catenin delta 2 (CTNND2) gene among HIV-positive women, and rs7529733 in the region intergenic to family with sequence similarity 5, member C and regulator of G-protein signaling 18 (FAM5C | RGS18) genes among HIV-negative women. The most significant local European ancestry associations were in the region intergenic to the zinc finger and SCAN domain containing 5D gene and NADH: ubiquinone oxidoreductase complex assembly factor 1 (ZSCAN5D | NDUF1) pseudogene on chromosome 19 among all women, in the region intergenic to vomeronasal 1 receptor 6 pseudogene and zinc finger protein 845 (VN1R6P | ZNF845) gene on chromosome 19 among HIV-positive women, and in the region intergenic to the SEC23-interacting protein and phosphatidic acid phosphatase type 2 domain containing 1A (SEC23IP | PPAPDC1A) genes located on chromosome 10 among HIV-negative women. A number of previously identified SNP associations with cCIMT were also observed and included rs2572204 in the ryanodine receptor 3 (RYR3) and an admixture region in the secretion-regulating guanine nucleotide exchange factor (SERGEF) gene. We report several SNPs and gene regions in the GWAS and admixture analysis, some of which are common across HIV-positive and HIV-negative women as demonstrated using meta-analysis, and also across the two analytic approaches (i.e., GWA and admixture). These findings suggest that local European ancestry plays an important role in genetic associations of cCIMT among black women from WIHS along with other environmental factors that are related to CVD and may also be triggered by HIV. These findings warrant confirmation in independent samples.
- Published
- 2017
26. Increased Antiretroviral Therapy Use and Virologic Suppression in the Bronx in the Context of Multiple HIV Prevention Strategies
- Author
-
Howard D. Strickler, Barry S. Zingman, David B. Hanna, Uriel R. Felsen, Kathryn Anastos, Mindy Ginsberg, Robert Beil, and Donna Futterman
- Subjects
0301 basic medicine ,Adult ,Male ,Pediatrics ,medicine.medical_specialty ,Adolescent ,Sustained Virologic Response ,Immunology ,Population ,Human immunodeficiency virus (HIV) ,Context (language use) ,HIV Infections ,medicine.disease_cause ,03 medical and health sciences ,Young Adult ,Virology ,Alternative Approaches to HIV Prevention ,medicine ,Disease Transmission, Infectious ,Outpatient clinic ,Humans ,Young adult ,education ,Aged ,Aged, 80 and over ,education.field_of_study ,business.industry ,Middle Aged ,Viral Load ,030112 virology ,Antiretroviral therapy ,Drug Utilization ,Infectious Diseases ,Anti-Retroviral Agents ,Test and treat ,RNA, Viral ,Female ,New York City ,business ,Viral load - Abstract
Multiple population-based HIV prevention strategies from national, state, local, and institutional levels have been implemented in the Bronx, which has one of the highest HIV prevalences in the U.S. We examined changes in antiretroviral therapy (ART) use and associated outcomes between 2007 and 2014 among patients seen at one of >20 outpatient clinics affiliated with the largest Bronx HIV care provider. Among eligible HIV-infected patients age ≥13 years, we examined annual trends in ART use, mean HIV RNA level, and virologic suppression (
- Published
- 2016
27. Trends in Nonlipid Cardiovascular Disease Risk Factor Management in the Women's Interagency HIV Study and Association with Adherence to Antiretroviral Therapy
- Author
-
Kathryn Anastos, Mary Young, Mardge H. Cohen, Xiaonan Xue, Nancy A. Hessol, Molly Jung, Robert C. Kaplan, Elizabeth T. Golub, Jennifer Cocohoba, David B. Hanna, Alexandra M. Levine, and Tracey E. Wilson
- Subjects
Blood Glucose ,Blood Pressure ,HIV Infections ,Disease ,030204 cardiovascular system & hematology ,Cardiovascular ,Diabetes treatment ,0302 clinical medicine ,cardiovascular disease ,Risk Factors ,Antiretroviral Therapy, Highly Active ,Prevalence ,030212 general & internal medicine ,Longitudinal Studies ,Clinical and Epidemiologic Research ,Diabetes ,Smoking ,virus diseases ,Women's Interagency HIV Study ,Fasting ,Middle Aged ,Viral Load ,Heart Disease ,Infectious Diseases ,Treatment Outcome ,6.1 Pharmaceuticals ,Hypertension ,Public Health and Health Services ,symbols ,HIV/AIDS ,Female ,Type 2 ,Adult ,medicine.medical_specialty ,hypertension ,antiretroviral therapy ,smoking ,Medication Adherence ,HIV-1 viral load ,03 medical and health sciences ,symbols.namesake ,Clinical Research ,Disease risk factor ,Virology ,Internal medicine ,Diabetes mellitus ,Diabetes Mellitus ,medicine ,Humans ,Highly Active ,Poisson regression ,business.industry ,Prevention ,Public Health, Environmental and Occupational Health ,Evaluation of treatments and therapeutic interventions ,medicine.disease ,Antiretroviral therapy ,United States ,Good Health and Well Being ,Blood pressure ,Diabetes Mellitus, Type 2 ,Physical therapy ,Smoking Cessation ,business ,Biomarkers - Abstract
Cardiovascular disease (CVD) is increasingly common among women with HIV, but literature on nonlipid CVD risk factor management is lacking. We examined semiannual trends from 2006 to 2014 in hypertension treatment and control (blood pressure
- Published
- 2016
28. Metabolomic changes in crown of alfalfa (Medicago sativa L.) during de-acclimation
- Author
-
Zhensong Li, Feng He, Zongyong Tong, Xianglin Li, Qingchuan Yang, and David B. Hannaway
- Subjects
Medicine ,Science - Abstract
Abstract Alfalfa is a high-quality forage legume species that is widely cultivated at high latitudes worldwide. However, a decrease in cold tolerance in early spring seriously affects regrowth and persistence of alfalfa. There has been limited research on the metabolomic changes that occur during de-acclimation. In this study, a liquid chromatography–mass spectrometry system was used to compare the metabolites in two alfalfa cultivars during a simulated overwintering treatment. In four pairwise comparisons, 367 differential metabolites were identified, of which 31 were annotated according to the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. Many of these metabolites were peptides, carbohydrates, and lipids. At the subclass level, 17 major pathways were revealed to be significantly enriched (P
- Published
- 2022
- Full Text
- View/download PDF
29. A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA-ACCORD and CCASAnet clinical cohorts
- Author
-
M. John Gill, David B. Hanna, Kate Buchacz, Carolyn Williams, Anita Rachlis, Sean B. Rourke, Juan Sierra-Madero, Angel M. Mayor, Beatriz Grinsztejn, Denis Padgett, Mari M. Kitahata, Peter F Rebeiro, Marcelo Wolff, Catherine C. McGowan, Jean W. Pape, Carina Cesar, Fernando Mejía Cordero, Keri N. Althoff, Alison G. Abraham, Pedro Cahn, Timothy R. Sterling, Robert S. Hogg, Jennifer E. Thorne, and Michael A. Horberg
- Subjects
Research design ,Gerontology ,Adult ,Male ,Cross-sectional study ,antiretroviral therapy ,Short Report ,HIV Infections ,purl.org/pe-repo/ocde/ford#3.03.08 [https] ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Acquired immunodeficiency syndrome (AIDS) ,Medicine ,Humans ,030212 general & internal medicine ,Cooperative Behavior ,10. No inequality ,Health policy ,implementation science ,retention in care ,030505 public health ,HIV indicators ,business.industry ,Health Policy ,Public Health, Environmental and Occupational Health ,Central America ,Middle Aged ,South America ,medicine.disease ,Health indicator ,CD4 T-lymphocyte count ,HIV Infections/drug therapy/epidemiology/immunology ,3. Good health ,CD4 Lymphocyte Count ,Infectious Diseases ,Cross-Sectional Studies ,Research Design ,HIV RNA suppression ,Cohort ,North America ,Map ,Female ,0305 other medical science ,business ,Viral load ,Cohort study ,Demography - Abstract
Introduction : Maps are powerful tools for visualization of differences in health indicators by geographical region, but multi-country maps of HIV indicators do not exist, perhaps due to lack of consistent data across countries. Our objective was to create maps of four HIV indicators in North, Central, and South American countries. Methods : Using data from the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) and the Caribbean, Central, and South America network for HIV epidemiology (CCASAnet), we mapped median CD4 at presentation for HIV clinical care, proportion retained in HIV primary care, proportion prescribed antiretroviral therapy (ART), and the proportion with suppressed plasma HIV viral load (VL) from 2010 to 2012 for North, Central, and South America. The 15 Canadian and US clinical cohorts and 7 clinical cohorts in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru represented approximately 2–7% of persons known to be living with HIV in these countries. Results : Study populations were selected for each indicator: median CD4 at presentation for care was estimated among 14,811 adults; retention was estimated among 87,979 adults; ART use was estimated among 84,757 adults; and suppressed VL was estimated among 51,118 adults. Only three US states and the District of Columbia had a median CD4 at presentation >350 cells/mm 3 . Haiti, Mexico, and several states had >85% retention in care; lower (50–74%) retention in care was observed in the US West, South, and Mid-Atlantic, and in Argentina, Brazil, and Peru. ART use was highest (90%) in Mexico. The percentages of patients with suppressed VL in the US South and Northeast were lower than in most of Central and South America. Conclusions : These maps provide visualization of gaps in the quality of HIV care and allow for comparison between and within countries as well as monitoring policy and programme goals within geographical boundaries. Keywords: Map; HIV indicators; CD4 T-lymphocyte count; retention in care; antiretroviral therapy; HIV RNA suppression; North America; Central America; South America; implementation science. To access the supplementary material to this article please see Supplementary Files in the column to the right (under Article Tools). (Published: 4 April 2016) Citation: Althoff KN et al. Journal of the International AIDS Society 2016, 19 :20707 http://www.jiasociety.org/index.php/jias/article/view/20707 | http://dx.doi.org/10.7448/IAS.19.1.20707
- Published
- 2016
30. Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort
- Author
-
Yanxia Chu, Kidane B. Ghebrehawariat, Alison Morris, Yingze Zhang, Lorrie Lucht, Matthew R. Gingo, David B. Hanna, Jong Hyeon Jeong, Jason Lazar, Quanwei Yang, and Mark T. Gladwin
- Subjects
Adult ,medicine.medical_specialty ,Population ,lcsh:Medicine ,HIV Infections ,Cohort Studies ,Sex Factors ,Risk Factors ,Internal medicine ,Antiretroviral Therapy, Highly Active ,Cause of Death ,Natriuretic Peptide, Brain ,medicine ,Humans ,Mortality ,Prospective cohort study ,education ,lcsh:Science ,2. Zero hunger ,education.field_of_study ,Multidisciplinary ,business.industry ,Mortality rate ,lcsh:R ,virus diseases ,Women's Interagency HIV Study ,Prognosis ,Peptide Fragments ,3. Good health ,Cohort ,Immunology ,Female ,lcsh:Q ,business ,Serostatus ,Body mass index ,Cohort study ,Research Article - Abstract
Background HIV-infected individuals are at increased risk of right and left heart dysfunction. N-terminal-pro-brain natriuretic peptide (NT-proBNP), a marker of cardiac ventricular strain and systolic dysfunction, may be associated with all-cause mortality in HIV-infected women. The aim of this study was to determine if elevated levels of NT-proBNP is associated with increased mortality in HIV-infected women. Design Prospective cohort study. Methods and Results We measured NT-proBNP in 936 HIV-infected and 387 age-matched HIV-uninfected women early (10/11/94 to 7/17/97) and 1082 HIV-infected and 448 HIV-uninfected women late (4/1/08 to 10/7/08) in the highly active antiretroviral therapy (HAART) periods in the Women’s Interagency HIV Study. An NT-proBNP >75th percentile was more likely in HIV-infected persons, but only statistically significant in the late period (27% vs. 21%, unadjusted p = 0.03). In HIV-infected participants, NT-proBNP>75th percentile was independently associated with worse 5-year survival in the early HAART period (HR 1.8, 95% CI 1.3–2.4, p
- Published
- 2015
31. INCREASE IN SINGLE-TABLET REGIMEN USE AND ASSOCIATED IMPROVEMENTS IN ADHERENCE-RELATED OUTCOMES IN HIV-INFECTED WOMEN
- Author
-
Nancy A. Hessol, Robert C. Kaplan, Elizabeth T. Golub, Mardge Cohen, Mary Young, David B. Hanna, Alexandra Levine, Kathryn Anastos, Tracey E. Wilson, and Jennifer Cocohoba
- Subjects
Adult ,medicine.medical_specialty ,Longitudinal study ,Anti-HIV Agents ,antiretroviral therapy ,Clinical Sciences ,HIV Infections ,time factors ,Article ,Medication Adherence ,Cohort Studies ,Quality of life ,Clinical Research ,Internal medicine ,Statistical significance ,Virology ,Antiretroviral Therapy, Highly Active ,Behavioral and Social Science ,medicine ,Humans ,Pharmacology (medical) ,Highly Active ,adherence ,Longitudinal Studies ,business.industry ,Evaluation of treatments and therapeutic interventions ,HIV ,Middle Aged ,Viral Load ,Confidence interval ,United States ,Regimen ,Infectious Diseases ,Treatment Outcome ,Relative risk ,6.1 Pharmaceuticals ,Propensity score matching ,Physical therapy ,Public Health and Health Services ,Quality of Life ,HIV/AIDS ,Female ,women ,business ,Infection ,Cohort study ,Tablets - Abstract
INTRODUCTION The use of single-tablet antiretroviral therapy (ART) regimens and its implications on adherence among HIV-infected women have not been well described. METHODS Participants were enrolled in the Women's Interagency HIV Study, a longitudinal study of HIV infection in US women. We examined semiannual trends in single-tablet regimen use and ART adherence, defined as self-reported 95% adherence in the past 6 months, during 2006-2013. In a nested cohort study, we assessed the comparative effectiveness of a single-tablet versus a multiple-tablet regimen with respect to adherence, virologic suppression, quality of life, and AIDS-defining events, using propensity score matching to account for demographic, behavioral, and clinical confounders. We also examined these outcomes in a subset of women switching from a multiple- to single-tablet regimen using a case-crossover design. RESULTS We included 15,523 person-visits, representing 1727 women (53% black, 29% Hispanic, 25% IDU, median age 47). Use of single-tablet regimens among ART users increased from 7% in 2006% to 27% in 2013; adherence increased from 78% to 85% during the same period (both P < 0.001). Single-tablet regimen use was significantly associated with increased adherence (adjusted risk ratio: 1.05; 95% confidence interval: 1.03 to 1.08) and virologic suppression (risk ratio: 1.06; 95% confidence interval: 1.01 to 1.11), while associations with improved quality of life and fewer AIDS-defining events did not achieve statistical significance. Similar findings were observed among the subset of switchers. CONCLUSIONS Single-tablet regimen use was associated with increased adherence and virologic suppression. Despite this, 15% of women prescribed ART were still not optimally adherent; additional interventions are needed to maximize therapeutic benefits.
- Published
- 2014
32. Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001–2009
- Author
-
David B, Hanna, Kate, Buchacz, Kelly A, Gebo, Nancy A, Hessol, Michael A, Horberg, Lisa P, Jacobson, Gregory D, Kirk, Mari M, Kitahata, P Todd, Korthuis, Richard D, Moore, Sonia, Napravnik, Pragna, Patel, Michael J, Silverberg, Timothy R, Sterling, James H, Willig, Bryan, Lau, Keri N, Althoff, Heidi M, Crane, Ann C, Collier, Hasina, Samji, Jennifer E, Thorne, M John, Gill, Marina B, Klein, Jeffrey N, Martin, Benigno, Rodriguez, Sean B, Rourke, Stephen J, Gange, and Adell, Mendes
- Subjects
Gerontology ,Male ,Psychological intervention ,HIV Infections ,Medical and Health Sciences ,time factors ,Substance Misuse ,Young adult ,Pediatric ,education.field_of_study ,Incidence ,Biological Sciences ,Middle Aged ,Viral Load ,Health equity ,Substance abuse ,Infectious Diseases ,Treatment Outcome ,North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS ,6.1 Pharmaceuticals ,Cohort ,HIV/AIDS ,Female ,Infection ,Viral load ,Microbiology (medical) ,Adult ,Canada ,Adolescent ,Anti-HIV Agents ,antiretroviral therapy ,Population ,Microbiology ,Young Adult ,Acquired immunodeficiency syndrome (AIDS) ,Clinical Research ,medicine ,Humans ,Healthcare Disparities ,education ,Proportional Hazards Models ,business.industry ,Prevention ,Evaluation of treatments and therapeutic interventions ,HIV ,medicine.disease ,United States ,Brain Disorders ,Good Health and Well Being ,Multivariate Analysis ,business ,Demography - Abstract
Since the mid-1990s, effective antiretroviral therapy (ART) regimens to treat human immunodeficiency virus (HIV) infection have improved in potency, tolerability, ease of use, and antiretroviral class diversity [1]. These have been linked to improvements in treatment adherence [2, 3] and clinical outcomes [4]. However, not all who are clinically eligible start treatment, a scenario sometimes associated with substance abuse and suboptimal insurance coverage, among other factors [5]. Monitoring trends in the successful initiation of ART is important, especially as population-based interventions such as expanded “test-and-treat” initiatives are introduced [6, 7] and as treatment guidelines recommend starting therapy at higher CD4+ counts [8, 9]. Collectively, these changes increase the identification of previously undiagnosed individuals and, consequently, the pool of persons newly eligible for treatment. Owing to their size and heterogeneity, collaborative observational studies are particularly useful to monitor trends [10]. They can help identify disparities among subpopulations, including those defined by geography, which may be informative as many health policies are instituted at the state or province level. Reducing HIV-related health disparities in vulnerable populations is a priority of both the US National HIV/AIDS Strategy and the Federal Initiative to Address HIV/AIDS in Canada [11, 12]. We examined ART initiation and virologic suppression among newly treatment-eligible individuals between 2001 and 2009 in the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). To assess changes over time in this large cohort, we estimated the annual cumulative incidence of ART initiation and virologic suppression following treatment eligibility. We also examined factors associated with these outcomes, and explored heterogeneity by geographic location.
- Published
- 2013
- Full Text
- View/download PDF
33. Erratic precipitation and clipping frequency reshape the community structure and species stability of Leymus chinensis steppe
- Author
-
Feng He, Zongyong Tong, David B. Hannaway, and Xianglin Li
- Subjects
Soil volumetric water content ,Soil temperature ,Clipping intensity ,Net primary productivity ,Importance value ,Temporal stability ,Ecology ,QH540-549.5 - Abstract
Leymus chinensis steppe is subject to degradation under the combined stresses of climate change and human disturbance. This study aimed to determine the independent and compound effects of precipitation and clipping frequency on the community structure and species temporal stability of L. chinensis steppe. Six treatments were applied in a 9-year field study, comprising three precipitation regimes (precipitation reduced by 50%, R1; unchanged from ambient precipitation, R2; and increased by 50%, R3) and two clipping frequencies (clipping once or twice per year, C1 and C2). We evaluated the soil hydrothermal status, dry matter, importance value and temporal stability of five important species (L. chinensis, Artemisia eriopoda, Cleistogenes squarrosa, Potentilla tanacetifolia, and Stipa krylovii) in the L. chinensis community. The results showed: Change in the soil volumetric water content (±2.4%) altered the competitive capability of L. chinensis relative to its associated species. Drought was beneficial to S. krylovii, wet status was favorable to C. squarrosa and P. tanacetifolia, whereas drought and a wet regime both reduced the importance value and temporal stability of L. chinensis. Erratic precipitation, rather than clipping frequency, decreased the temporal stability of L. chinensis. Net primary productivity and dry matter of L. chinensis were strongly correlated under drought or wet regimes. Restoration of the key species L. chinensis and controlling grazing intensity in severe drought or wet conditions are recommended strategies for sustainable management of L. chinensis steppe.
- Published
- 2021
- Full Text
- View/download PDF
34. Effect of Storage Period on the Fermentation Profile and Bacterial Community of Silage Prepared with Alfalfa, Whole-Plant Corn and Their Mixture
- Author
-
Kai Mao, Zhu Yu, Shuai Huang, Musen Wang, and David B. Hannaway
- Subjects
co-ensiling ,conservation duration ,lactic acid bacteria ,homo-fermentation ,hetero-fermentation ,Fermentation industries. Beverages. Alcohol ,TP500-660 - Abstract
This study aimed to investigate the impact of storage time on the bacterial community and fermentation profile of silage prepared with alfalfa, whole-plant corn, and their mixture. Fresh alfalfa and whole-plant corn were chopped and combined in fresh weight ratios of 1:0 (alfalfa, control), 0.8:0.2 (M1), 0.6:0.4 (M2), and 0:1 (corn). Three silos of each treatment were analyzed after 30, 60, and 90 d of storage. With storage time, pH, acetic acid, propionic acid, butyric acid, and ammonia nitrogen levels increased in alfalfa silage (p < 0.01), whereas lactic acid level decreased (p < 0.01). Compared to alfalfa silage, M1, M2, and corn silages were better fermented and more stable during storage. The dominant bacteria in M1, M2, and corn silages shifted significantly from L. plantarum, L. buchneri, and L. brevis to L. acetotolerans and L. buchneri during 30 to 60–90 d of storage, and storage time decreased the bacterial diversity of these silages. In conclusion, storage time significantly decreased the fermentation quality of alfalfa silage and remarkably optimized the bacterial community structure of well-fermented M1, M2, and corn silages. Alfalfa should be ensiled with at least 20% whole-plant corn to improve silage fermentation quality and storage stability.
- Published
- 2022
- Full Text
- View/download PDF
35. Pesticide use in vegetable production: A survey of Vietnamese farmers' knowledge
- Author
-
Thanh Mai Nguyen, Nga Thi Thanh Le, Jouni Havukainen, and David B. Hannaway
- Subjects
pesticide application ,pesticide disposal ,vegetable pesticide residues ,environmental protection ,agricultural production ,vietnam agriculture ,Plant culture ,SB1-1110 - Abstract
Concerns about inappropriate storage, application rates, and disposal practices of pesticides prompted this case study of Vietnamese farmers' knowledge, attitudes, and practices. 128 small-scale vegetable growers in Lam Dong Province were included in field surveys, questionnaires, and interviews. Farmers reported inappropriate mixing of pesticides and disposal methods. Many also reported ill-timed applications posing potential hazards to the human health and environment. Improved training and monitoring of pesticide residues on foodstuffs and in agricultural soils and community water supplies are needed to ensure safe farmer practices. Community-based training and education, jointly funded by local, national, and international agricultural production and food safety groups, would be a cost-effective method of minimising pesticide applications and improving food safety.
- Published
- 2018
- Full Text
- View/download PDF
36. Effect of Mixing Alfalfa with Whole-Plant Corn in Different Proportions on Fermentation Characteristics and Bacterial Community of Silage
- Author
-
Musen Wang, Run Gao, Marcia Franco, David B. Hannaway, Wencan Ke, Zitong Ding, Zhu Yu, and Xusheng Guo
- Subjects
conservation characteristics ,forages mixing ,microflora ,Medicago sativa ,Zea mays ,Agriculture (General) ,S1-972 - Abstract
The influence of mixing alfalfa with whole-plant corn in different proportions on the fermentation characteristics and bacterial community of silage was investigated. Alfalfa and whole-plant corn, harvested at dry matter content of 276.47 and 328.43 g/kg fresh weight, accordingly, were chopped to approximately 2 cm and mixed at ratios of 100:0 (C0, control), 80:20 (C20), 60:40 (C40), 40:60 (C60), 20:80 (C80) and 0:100 (C100) on a fresh weight basis, respectively. Silos of each treatment were produced in triplicate and anaerobically fermented in darkness for 100 days at room temperature (20–21 °C). At silo opening, silage fermentation characteristics and bacterial composition and diversity were analyzed. The C0 silage was weakly preserved, evidenced by a low lactic acid concentration and a high value of pH, acetic acid, propionic acid, butyric acid and ammonia nitrogen. With corn proportion in the mixture increasing from 0% to 40%, silage pH, acetic acid, butyric acid and ammonia nitrogen level decreased, whereas the value of lactic acid and lactic acid to acetic acid ratio increased. The C40, C60, C80 and C100 silages’ Flieg score, used to evaluate the overall fermentation quality, was above 80 and higher than C0 (25) and C20 (61) silages. The C0 silage contained a complex bacterial community at the genus level, consisting mainly of Enterococcus (38.86%), Enterobacteria (20.61%), Rhizobium (8.45%), Lactobacillus (8.15%), Methylobacterium (5.54%) and Weissella (5.24%). As corn percentage increased from 0% to 40%, the relative abundance of desirable Lactobacillus increased and undesirable Rhizobium and Methylobacterium population reduced. With corn proportion in the mixture increasing from 0% to 40%, inclusion of corn to alfalfa at ensiling significantly improved silage fermentation quality and shifted the bacterial community for better silage preservation. Overall, high quality silage was produced when alfalfa was combined with at least 40% whole-plant corn on a fresh weight basis.
- Published
- 2021
- Full Text
- View/download PDF
37. HIV infection and cardiovascular disease have both shared and distinct monocyte gene expression features: Women's Interagency HIV study.
- Author
-
Juan Lin, Erik Ehinger, David B Hanna, Qibin Qi, Tao Wang, Yanal Ghosheh, Karin Mueller, Kathryn Anastos, Jason M Lazar, Wendy J Mack, Phyllis C Tien, Joan W Berman, Mardge H Cohen, Igho Ofotokun, Stephen Gange, Chenglong Liu, Sonya L Heath, Russell P Tracy, Howard N Hodis, Alan L Landay, Klaus Ley, and Robert C Kaplan
- Subjects
Medicine ,Science - Abstract
Persistent inflammation contributes to the development of cardiovascular disease (CVD) as an HIV-associated comorbidity. Innate immune cells such as monocytes are major drivers of inflammation in men and women with HIV. The study objectives are to examine the contribution of circulating non-classical monocytes (NCM, CD14dimCD16+) and intermediate monocytes (IM, CD14+CD16+) to the host response to long-term HIV infection and HIV-associated CVD. Women with and without chronic HIV infection (H) were studied. Subclinical CVD (C) was detected as plaques imaged by B-mode carotid artery ultrasound. The study included H-C-, H+C-, H-C+, and H+C+ participants (23 of each, matched on race/ethnicity, age and smoking status), selected from among enrollees in the Women's Interagency HIV Study. We assessed transcriptomic features associated with HIV or CVD alone or comorbid HIV/CVD comparing to healthy (H-C-) participants in IM and NCM isolated from peripheral blood mononuclear cells. IM gene expression was little affected by HIV alone or CVD alone. In IM, coexisting HIV and CVD produced a measurable gene transcription signature, which was abolished by lipid-lowering treatment. In NCM, versus non-HIV controls, women with HIV had altered gene expression, irrespective of whether or not they had comorbid CVD. The largest set of differentially expressed genes was found in NCM among women with both HIV and CVD. Genes upregulated in association with HIV included several potential targets of drug therapies, including LAG3 (CD223). In conclusion, circulating monocytes from patients with well controlled HIV infection demonstrate an extensive gene expression signature which may be consistent with the ability of these cells to serve as potential viral reservoirs. Gene transcriptional changes in HIV patients were further magnified in the presence of subclinical CVD.
- Published
- 2023
- Full Text
- View/download PDF
38. Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS).
- Author
-
Aditi Shendre, Howard W Wiener, Marguerite R Irvin, Bradley E Aouizerat, Edgar T Overton, Jason Lazar, Chenglong Liu, Howard N Hodis, Nita A Limdi, Kathleen M Weber, Stephen J Gange, Degui Zhi, Michelle A Floris-Moore, Ighovwerha Ofotokun, Qibin Qi, David B Hanna, Robert C Kaplan, and Sadeep Shrestha
- Subjects
Medicine ,Science - Abstract
Cardiovascular disease (CVD) is a major comorbidity among HIV-infected individuals. Common carotid artery intima-media thickness (cCIMT) is a valid and reliable subclinical measure of atherosclerosis and is known to predict CVD. We performed genome-wide association (GWA) and admixture analysis among 682 HIV-positive and 288 HIV-negative Black, non-Hispanic women from the Women's Interagency HIV study (WIHS) cohort using a combined and stratified analysis approach. We found some suggestive associations but none of the SNPs reached genome-wide statistical significance in our GWAS analysis. The top GWAS SNPs were rs2280828 in the region intergenic to mediator complex subunit 30 and exostosin glycosyltransferase 1 (MED30 | EXT1) among all women, rs2907092 in the catenin delta 2 (CTNND2) gene among HIV-positive women, and rs7529733 in the region intergenic to family with sequence similarity 5, member C and regulator of G-protein signaling 18 (FAM5C | RGS18) genes among HIV-negative women. The most significant local European ancestry associations were in the region intergenic to the zinc finger and SCAN domain containing 5D gene and NADH: ubiquinone oxidoreductase complex assembly factor 1 (ZSCAN5D | NDUF1) pseudogene on chromosome 19 among all women, in the region intergenic to vomeronasal 1 receptor 6 pseudogene and zinc finger protein 845 (VN1R6P | ZNF845) gene on chromosome 19 among HIV-positive women, and in the region intergenic to the SEC23-interacting protein and phosphatidic acid phosphatase type 2 domain containing 1A (SEC23IP | PPAPDC1A) genes located on chromosome 10 among HIV-negative women. A number of previously identified SNP associations with cCIMT were also observed and included rs2572204 in the ryanodine receptor 3 (RYR3) and an admixture region in the secretion-regulating guanine nucleotide exchange factor (SERGEF) gene. We report several SNPs and gene regions in the GWAS and admixture analysis, some of which are common across HIV-positive and HIV-negative women as demonstrated using meta-analysis, and also across the two analytic approaches (i.e., GWA and admixture). These findings suggest that local European ancestry plays an important role in genetic associations of cCIMT among black women from WIHS along with other environmental factors that are related to CVD and may also be triggered by HIV. These findings warrant confirmation in independent samples.
- Published
- 2017
- Full Text
- View/download PDF
39. A picture is worth a thousand words: maps of HIV indicators to inform research, programs, and policy from NA‐ACCORD and CCASAnet clinical cohorts
- Author
-
Keri N Althoff, Peter F Rebeiro, David B Hanna, Denis Padgett, Michael A Horberg, Beatriz Grinsztejn, Alison G Abraham, Robert Hogg, M John Gill, Marcelo J Wolff, Angel Mayor, Anita Rachlis, Carolyn Williams, Timothy R Sterling, Mari M Kitahata, Kate Buchacz, Jennifer E Thorne, Carina Cesar, Fernando M Cordero, Sean B Rourke, Juan Sierra‐Madero, Jean W Pape, Pedro Cahn, Catherine McGowan, and for the North American Aids Cohort Collaboration on Research and Design (na‐Accord) and the Caribbean, Central and the South America Network for Hiv Epidemiology (ccasanet)
- Subjects
Map ,HIV indicators ,CD4 T‐lymphocyte count ,retention in care ,antiretroviral therapy ,HIV RNA suppression ,Immunologic diseases. Allergy ,RC581-607 - Abstract
Introduction Maps are powerful tools for visualization of differences in health indicators by geographical region, but multi‐country maps of HIV indicators do not exist, perhaps due to lack of consistent data across countries. Our objective was to create maps of four HIV indicators in North, Central, and South American countries. Methods Using data from the North American AIDS Cohort Collaboration on Research and Design (NA‐ACCORD) and the Caribbean, Central, and South America network for HIV epidemiology (CCASAnet), we mapped median CD4 at presentation for HIV clinical care, proportion retained in HIV primary care, proportion prescribed antiretroviral therapy (ART), and the proportion with suppressed plasma HIV viral load (VL) from 2010 to 2012 for North, Central, and South America. The 15 Canadian and US clinical cohorts and 7 clinical cohorts in Argentina, Brazil, Chile, Haiti, Honduras, Mexico, and Peru represented approximately 2–7% of persons known to be living with HIV in these countries. Results Study populations were selected for each indicator: median CD4 at presentation for care was estimated among 14,811 adults; retention was estimated among 87,979 adults; ART use was estimated among 84,757 adults; and suppressed VL was estimated among 51,118 adults. Only three US states and the District of Columbia had a median CD4 at presentation >350 cells/mm3. Haiti, Mexico, and several states had >85% retention in care; lower (50–74%) retention in care was observed in the US West, South, and Mid‐Atlantic, and in Argentina, Brazil, and Peru. ART use was highest (90%) in Mexico. The percentages of patients with suppressed VL in the US South and Northeast were lower than in most of Central and South America. Conclusions These maps provide visualization of gaps in the quality of HIV care and allow for comparison between and within countries as well as monitoring policy and programme goals within geographical boundaries.
- Published
- 2016
- Full Text
- View/download PDF
40. Elevated NT-pro-brain natriuretic peptide level is independently associated with all-cause mortality in HIV-infected women in the early and recent HAART eras in the Women's Interagency HIV Study cohort.
- Author
-
Matthew R Gingo, Yingze Zhang, Kidane B Ghebrehawariat, Jong-Hyeon Jeong, Yanxia Chu, Quanwei Yang, Lorrie Lucht, David B Hanna, Jason M Lazar, Mark T Gladwin, and Alison Morris
- Subjects
Medicine ,Science - Abstract
HIV-infected individuals are at increased risk of right and left heart dysfunction. N-terminal-pro-brain natriuretic peptide (NT-proBNP), a marker of cardiac ventricular strain and systolic dysfunction, may be associated with all-cause mortality in HIV-infected women. The aim of this study was to determine if elevated levels of NT-proBNP is associated with increased mortality in HIV-infected women.Prospective cohort study.We measured NT-proBNP in 936 HIV-infected and 387 age-matched HIV-uninfected women early (10/11/94 to 7/17/97) and 1082 HIV-infected and 448 HIV-uninfected women late (4/1/08 to 10/7/08) in the highly active antiretroviral therapy (HAART) periods in the Women's Interagency HIV Study. An NT-proBNP >75th percentile was more likely in HIV-infected persons, but only statistically significant in the late period (27% vs. 21%, unadjusted p = 0.03). In HIV-infected participants, NT-proBNP>75th percentile was independently associated with worse 5-year survival in the early HAART period (HR 1.8, 95% CI 1.3-2.4, p
- Published
- 2015
- Full Text
- View/download PDF
41. Association between U.S. state AIDS Drug Assistance Program (ADAP) features and HIV antiretroviral therapy initiation, 2001-2009.
- Author
-
David B Hanna, Kate Buchacz, Kelly A Gebo, Nancy A Hessol, Michael A Horberg, Lisa P Jacobson, Gregory D Kirk, Mari M Kitahata, P Todd Korthuis, Richard D Moore, Sonia Napravnik, Pragna Patel, Michael J Silverberg, Timothy R Sterling, James H Willig, Ann Collier, Hasina Samji, Jennifer E Thorne, Keri N Althoff, Jeffrey N Martin, Benigno Rodriguez, Elizabeth A Stuart, Stephen J Gange, and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA)
- Subjects
Medicine ,Science - Abstract
BACKGROUND:U.S. state AIDS Drug Assistance Programs (ADAPs) are federally funded to provide antiretroviral therapy (ART) as the payer of last resort to eligible persons with HIV infection. States differ regarding their financial contributions to and ways of implementing these programs, and it remains unclear how this interstate variability affects HIV treatment outcomes. METHODS:We analyzed data from HIV-infected individuals who were clinically-eligible for ART between 2001 and 2009 (i.e., a first reported CD4+
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.